The Clinical Predictive Value (or Lack Thereof) of the Results of In Vitro Antimicrobial Susceptibility Tests
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Estimates of antibacterial activity can be determined using a wide variety of different in vitro methods. These include manual methods such as disk diffusion, broth microdilution, and Etests or instrument-based methods such as Vitek (bioMerieux, Durham, NC), Phoenix (BD, Franklin Lakes, NJ),
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fungal infections generally follow the”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [4]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“MIC measurements have been optimized to minimize or ignore residual fungal growth 4,18 , termed”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement
Cockerill, F. R., & Clinical (2008) · Medical Entomology and Zoology · Cited by 2,065
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Hilf, M., Yu, V. L., Sharp, J., Zuravleff, J. J., Korvick, J. A., & Muder, R. R. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90695-5 · Cited by 563
Weinstein, M. P., Murphy, J. R., Reller, L. B., & Lichtenstein, K. A. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.1.54 · Cited by 472
Has antifungal susceptibility testing come of age
Rex, J. H., & Pfaller, M. A. (2002) · Clinical Infectious Diseases · doi:10.1086/342384 · Cited by 361 · cited 2×
“and Pfaller (18) to coin the phrase, “the 90–60 rule” when”
Clinical and economic burden of antimicrobial resistance
Maragakis, L. L., Perencevich, E. N., & Cosgrove, S. E. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.751 · Cited by 329
Nguyen, M. H., Yu, V. L., Morris, A. J., McDermott, L., Wagener, M. W., Harrell, L., & Snydman, D. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313805 · Cited by 215
Detection and Treatment of Bloodstream Infection: Laboratory Reporting and Antimicrobial Management
Munson, E. L., Diekema, D. J., Beekmann, S. E., Chapin, K. C., & Doern, G. V. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.495-497.2003 · Cited by 191
Self-citationAcute Cystitis: A Prospective Study of Laboratory Tests and Duration of Therapy
Schultz, H. J., McCAFFREY, L. A., Keys, T. F., & Nobrega, F. T. (1984) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61461-x · Cited by 99
Binkley, S., Fishman, N. O., LaRosa, L. A., Marr, A. M., Nachamkin, I., Wordell, D. C., Bilker, W. B., & Lautenbach, E. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/505921 · Cited by 96
Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay
Bosanquet, A. G. (1991) · The Lancet · doi:10.1016/0140-6736(91)90287-y · Cited by 83
Yang, Y., Ku, C., Lin, J., et al. (2010) · Journal of Microbiology Immunology and Infection · doi:10.1016/s1684-1182(10)60031-x · Cited by 68
Snydman, D. R., Cuchural, G. J., McDermott, L., & Gill, M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.3.540 · Cited by 55
Discrepancies between in vitro activity of and in vivo response to antimicrobial agents
Washington, J. A. (1983) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(83)90029-9 · Cited by 49
DeFife, R., Scheetz, M. H., Feinglass, J. M., Postelnick, M. J., & Scarsi, K. K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00580-08 · Cited by 45
Jones, R. N., & Dudley, M. N. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00013-8 · Cited by 42
Molecular Detection of Resistance Determinants
Ledeboer, N. A., & Hodinka, R. L. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00771-11 · Cited by 35
In vitro activity of loracarbef and effects of susceptibility test methods
Doern, G. V. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90601-7 · Cited by 23
Self-citationBantar, C., Alcázar, G., Franco, D., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl434 · Cited by 22
Worldwide Clinical Experience with Cefoperazone
Gerber, A., & Craig, W. A. (1981) · Drugs · doi:10.2165/00003495-198100221-00022 · Cited by 20
Short‐Term and Medium‐Term Clinical Outcomes of Quinolone‐ResistantCampylobacterInfection
Evans, M. R., Northey, G., Sarvotham, T., Rigby, C. J., Hopkins, A., & Thomas, D. R. (2009) · Clinical Infectious Diseases · doi:10.1086/598932 · Cited by 17
Interpretive criteria for in vitro antimicrobial susceptibility tests
Doern, G. V. (1995) · Reviews in Medical Microbiology · doi:10.1097/00013542-199504000-00006 · Cited by 8
Self-citation
Research works printed but not linked: 2
- 10.1016/S0002-9343(89)80611-4 · doi:10.1016/s0002-9343(89)80611-4 · Paper page
- MurrayP. R. JonesR. NovickW.. 1983. Analysis of the clinical predictive value of quantitative and qualitative susceptibility tests with cefotaxime. Abstr. 23rd Intersci. Conf. Antimicrob. Agents Chemother. abstr. 545, p. 182.
Cited by
The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
Kowalska-Krochmal, B., & Dudek-Wicher, R. (2021) · Pathogens · doi:10.3390/pathogens10020165 · Cited by 1,039
Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
“Studying growth dynamics and quantifying tolerance revealed that it is: (1) a subpopulation effect and the size of the subpopulation is stable; (2) due to slow growth in drug stress; (3) correlates with intracellular drug levels; (4) dependent upon stress response pathways, and (5) mechanistically distinct from resist…”
BackgroundDe Briyne, N., Atkinson, J., Pokludová, L., Borriello, S. P., & Price, S. (2013) · Veterinary Record · doi:10.1136/vr.101454 · Cited by 236
Sarchet, J. J., Pollreisz, J. P., Bechtol, D. T., Blanding, M. R., Saltman, R. L., & Taube, P. C. (2022) · PLOS ONE · doi:10.1371/journal.pone.0247213 · Cited by 14
Metadata
- Authors
- Doern, G. V., & Brecher, S. M.
- Affiliations
- University of Iowa (US)
- VA Boston Healthcare System (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2011-09
- Volume
- 49
- Issue
- 9_Supplement
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3185848
- OpenAlex
- W2013292084
- Cited by
- 132
- References
- 23
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 7 · 2023: 14 · 2022: 3 · 2021: 7 · 2020: 18 · 2019: 14 · 2018: 8 · 2017: 11 · 2016: 7 · 2015: 8 · 2014: 5 · 2013: 5 · 2012: 5
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial susceptibility testing, in vitro antimicrobial susceptibility, disk diffusion, broth microdilution, E-test, Vitek, antibacterial activity, clinical isolates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.